The Efficacy and Safety Study of Thymosin Α1 Combined with PD-1 Antibodies As Adjuvant Therapy in Patients with Hepatocellular Carcinoma with High-Risk Recurrence Factors after Radical Resection.
Journal of Clinical Oncology（2024）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined